SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-07-000002
Filing Date
2007-01-10
Accepted
2007-01-10 10:49:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G HOLDINGS REPORT AMENDMENT nps0107.txt SC 13G/A 11511
  Complete submission text file 0001172661-07-000002.txt   13290
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Subject) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-44877 | Film No.: 07522198
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 767 3RD AVENUE 30TH FLOOR NEW YORK NY 10017
Business Address 767 3RD AVENUE 30TH FLOOR NEW YORK NY 10017 2126845700
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13G/A